These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 1279719

  • 1. Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assay.
    Janssen WE, Lee C, Farmelo MJ, Smilee R, Barth K, Fields KK, Zorsky PE, Elfenbein GJ.
    Prog Clin Biol Res; 1992; 377():513-21. PubMed ID: 1279719
    [No Abstract] [Full Text] [Related]

  • 2. Ex vivo expansion of CD34+ hematopoietic progenitors.
    Moore MA, Schneider JG, Shapiro F, Bengala C.
    Prog Clin Biol Res; 1994; 389():217-28. PubMed ID: 7535432
    [No Abstract] [Full Text] [Related]

  • 3. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
    Wunder E, Sovalat H, Liang H, Becker M, Henon P.
    Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
    [No Abstract] [Full Text] [Related]

  • 4. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
    Cottler-Fox M, Read EJ, Yu M, Carter C, Klein HG.
    Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
    [No Abstract] [Full Text] [Related]

  • 5. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
    Petsche D, Hami L, Purdy M, Myers S, Hogan C, Messner H, Briddell R, Heimfeld S, Berenson R, Shpall E.
    Prog Clin Biol Res; 1994; 389():415-20. PubMed ID: 7535450
    [No Abstract] [Full Text] [Related]

  • 6. Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
    Siena S, Bregni M, Gianni AM.
    Exp Hematol; 1993 Feb; 21(2):203-5. PubMed ID: 7678809
    [No Abstract] [Full Text] [Related]

  • 7. Quality control for peripheral stem cell collection: the Ottawa experience.
    Giulivi A, Huebsch LB, Van der Jagt R, Markman S, Fuller V, Birch P, Demone J, McDiermid S, Rutherford B.
    Prog Clin Biol Res; 1994 Feb; 389():753-9. PubMed ID: 7535465
    [No Abstract] [Full Text] [Related]

  • 8. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
    Inaba T, Shimazaki C, Tatsumi T, Yamagata N, Hirata T, Goto H, Fujita N, Nakagawa M.
    Prog Clin Biol Res; 1994 Feb; 389():331-7. PubMed ID: 7535439
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD34 analysis in peripheral blood correlates with colony forming capacity--an update.
    Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H.
    Prog Clin Biol Res; 1992 Feb; 377():531-6. PubMed ID: 1279721
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J.
    Blood Cells; 1994 Feb; 20(2-3):411-23. PubMed ID: 7538347
    [Abstract] [Full Text] [Related]

  • 13. CD34 positive cell selection by immunomagnetic techniques.
    Bigas A, Amill B, Canals C, Tugues D, García J.
    Prog Clin Biol Res; 1992 Feb; 377():545-51. PubMed ID: 1279723
    [No Abstract] [Full Text] [Related]

  • 14. CD34+ and CD33+ stem cells: predictors of hematologic recovery?
    Ross RE, Jeter EK, Stuart RK, Self SE, Lavia MF.
    Prog Clin Biol Res; 1992 Feb; 377():505-12. PubMed ID: 1279718
    [No Abstract] [Full Text] [Related]

  • 15. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C, Maciejewski JP, De Rosa G, Raiola A, Risitano AM, Picardi M, Pezzullo L, Luciano L, Ricci P, Varriale G, Della Cioppa P, Del Vecchio L, Rotoli B.
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [Abstract] [Full Text] [Related]

  • 16. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ, Zimmerman T, Meyers S, Bender JG, Williams SF.
    Prog Clin Biol Res; 1994 May; 389():421-7. PubMed ID: 7535451
    [No Abstract] [Full Text] [Related]

  • 17. CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
    O'Kane-Murphy B, Jackson JD, Kuszynski C, Costas P, Wang PN, Warkentin PI, Kessinger A.
    Prog Clin Biol Res; 1994 May; 389():371-6. PubMed ID: 7535444
    [No Abstract] [Full Text] [Related]

  • 18. Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: an in vitro study to determine optimal timing of exposure to early acting cytokines.
    Ratajczak MZ, Ratajczak J, Kregenow DA, Gewirtz AM.
    Stem Cells; 1994 Nov; 12(6):599-603. PubMed ID: 7533578
    [Abstract] [Full Text] [Related]

  • 19. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
    Cipolone KM, Carter CS, Yu M, Cottler-Fox M.
    Prog Clin Biol Res; 1994 Nov; 389():667-73. PubMed ID: 7535463
    [No Abstract] [Full Text] [Related]

  • 20. Single and multicolor flow cytometric CD34 analysis in different cell sources.
    Fritsch G, Ströbel T, Dworzak MD, Buchinger P, Printz D, Gadner H.
    Prog Clin Biol Res; 1994 Nov; 389():325-30. PubMed ID: 7535438
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.